Drug Type Gene therapy |
Synonyms- |
Target |
Action modulators |
Mechanism FANCA modulators(Fanconi anemia group A protein modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Tyrosinemias | Preclinical | United States | 11 Apr 2019 |